DrugPatentWatch Database Preview
TENUATE DOSPAN Drug Profile
» See Plans and Pricing
When do Tenuate Dospan patents expire, and when can generic versions of Tenuate Dospan launch?
Tenuate Dospan is a drug marketed by Nostrum Labs Inc and is included in one NDA.
The generic ingredient in TENUATE DOSPAN is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Tenuate Dospan
A generic version of TENUATE DOSPAN was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
Summary for TENUATE DOSPAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 29 |
| Patent Applications: | 581 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TENUATE DOSPAN at DailyMed |
Pharmacology for TENUATE DOSPAN
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
US Patents and Regulatory Information for TENUATE DOSPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
